B7-H1-deficiency enhances the potential of tolerogenic dendritic cells by activating CD1d-restricted type II NKT cells.

Brandl, Carolin

B7-H1-deficiency enhances the potential of tolerogenic dendritic cells by activating CD1d-restricted type II NKT cells. [electronic resource] - PloS one May 2010 - e10800 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1932-6203

10.1371/journal.pone.0010800 doi


Animals
Antigens, CD1d--immunology
Antigens, Surface--metabolism
Apoptosis Regulatory Proteins--metabolism
B7-1 Antigen--metabolism
B7-H1 Antigen
Biomarkers--metabolism
CD4-Positive T-Lymphocytes--drug effects
Cell Line
Cell Membrane--drug effects
Central Nervous System--drug effects
Dendritic Cells--drug effects
Encephalomyelitis, Autoimmune, Experimental--immunology
Epitopes--immunology
Lymphocyte Activation--drug effects
Membrane Glycoproteins--deficiency
Mice
Natural Killer T-Cells--drug effects
Organic Chemicals--immunology
Peptides--deficiency
Programmed Cell Death 1 Receptor
Tumor Necrosis Factor-alpha--administration & dosage